Items Tagged ‘elderly’

August 9th, 2016

Pracinostat Receives Breakthrough Therapy Designation from FDA for Treatment in Combination with Azacitidine of Patients with Newly Diagnosed Acute Myeloid Leukemia

By

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational drug Pracinostat in combination with azacitidine for the treatment of elderly patients with newly diagnosed acute myeloid leukemia (AML). Acute myeloid leukemia (AML) is a cancer of the bone marrow (spongy portion found in the middle of bones) and blood […]

View full entry

Tags: Acute Myeloid Leukemia, AML, azacitidine, Breakthrough Therapy Designation, elderly, FDA. BTD, HDACs, Leukemia, News, Pracinostat


June 8th, 2016

Tecentriq® Effective as Initial Therapy in Advanced Bladder Cancer

By

The immunotherapy agent Tecentriq® (atezolizumab) provides anti-cancer activity when used as initial therapy among patients with advanced bladder cancer who are not able to tolerate standard therapy. These results were recently presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO). Bladder cancer will be diagnosed in approximately 77,000 people in […]

View full entry

Tags: advanced, atezolizumab, Bladder Cancer, elderly, immunotherapy Tecentriq, News, smokers, Stage IV/Metastatic Bladder Cancer, urothlial carcinoma


August 31st, 2015

High Use of Alternative Medicine in Senior Cancer Patients

By

Alternative medicines are widely thought to be at least harmless and very often helpful for a wide range of discomforts and illnesses. However, although they’re marketed as “natural,” they often contain active ingredients that can react chemically and biologically with other therapies. Researchers performed a comprehensive review of all of the medications taken by senior […]

View full entry

Tags: All Cancer Types, CAM, cancer, complementary or alternative medicines, elderly, News, oncology, reaction, risk